agreal has been researched along with Parkinson Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergareche, A; López de Munain, A; Martí Massó, JF; Ruiz-Martínez, J | 1 |
Andréjak, M; Geslin, JM; Gras-Champel, V; Lemaire-Hurtel, AS; Masmoudi, K; Masson, H; Munier, A | 1 |
Sa, DS; Teive, HA | 1 |
3 other study(ies) available for agreal and Parkinson Disease
Article | Year |
---|---|
[Parkinsonism induced by sulpiride and veralipride: two different stories].
Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Humans; Male; Middle Aged; Molecular Structure; Nervous System Diseases; Parkinson Disease; Parkinsonian Disorders; Retrospective Studies; Safety-Based Drug Withdrawals; Spain; Structure-Activity Relationship; Sulpiride; Torticollis | 2011 |
[Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].
Topics: Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Sulpiride | 2005 |
Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.
Topics: Dopamine Antagonists; Female; Humans; Menopause; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Sulpiride | 2001 |